BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Camara-Lemarroy CR, Metz L, Meddings JB, Sharkey KA, Wee Yong V. The intestinal barrier in multiple sclerosis: implications for pathophysiology and therapeutics. Brain. 2018;141:1900-1916. [PMID: 29860380 DOI: 10.1093/brain/awy131] [Cited by in Crossref: 50] [Cited by in F6Publishing: 48] [Article Influence: 16.7] [Reference Citation Analysis]
Number Citing Articles
1 LaGamma EF, Hu F, Pena Cruz F, Bouchev P, Nankova BB. Bacteria - derived short chain fatty acids restore sympathoadrenal responsiveness to hypoglycemia after antibiotic-induced gut microbiota depletion. Neurobiol Stress 2021;15:100376. [PMID: 34401412 DOI: 10.1016/j.ynstr.2021.100376] [Reference Citation Analysis]
2 Yang Y, Musco H, Simpson-Yap S, Zhu Z, Wang Y, Lin X, Zhang J, Taylor B, Gratten J, Zhou Y. Investigating the shared genetic architecture between multiple sclerosis and inflammatory bowel diseases. Nat Commun 2021;12:5641. [PMID: 34561436 DOI: 10.1038/s41467-021-25768-0] [Reference Citation Analysis]
3 Rossi B, Santos-Lima B, Terrabuio E, Zenaro E, Constantin G. Common Peripheral Immunity Mechanisms in Multiple Sclerosis and Alzheimer's Disease. Front Immunol 2021;12:639369. [PMID: 33679799 DOI: 10.3389/fimmu.2021.639369] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
4 Camara-Lemarroy CR. Can Our Guts Tell Us Anything About MS? J Neuroimmune Pharmacol 2019;14:367-8. [PMID: 30771156 DOI: 10.1007/s11481-019-09841-6] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
5 Buscarinu MC, Fornasiero A, Romano S, Ferraldeschi M, Mechelli R, Reniè R, Morena E, Romano C, Pellicciari G, Landi AC, Salvetti M, Ristori G. The Contribution of Gut Barrier Changes to Multiple Sclerosis Pathophysiology. Front Immunol 2019;10:1916. [PMID: 31555257 DOI: 10.3389/fimmu.2019.01916] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 4.7] [Reference Citation Analysis]
6 Avasarala J, Guduru Z, McLouth CJ, Wilburn A, Talbert J, Sutton P, Sokola BS. Use of anti-TNF-α therapy in Crohn's disease is associated with increased incidence of multiple sclerosis. Mult Scler Relat Disord 2021;51:102942. [PMID: 33933908 DOI: 10.1016/j.msard.2021.102942] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Luo C, Huang C, Zhu L, Kong L, Yuan Z, Wen L, Li R, Wu J, Yi J. Betulinic Acid Ameliorates the T-2 Toxin-Triggered Intestinal Impairment in Mice by Inhibiting Inflammation and Mucosal Barrier Dysfunction through the NF-κB Signaling Pathway. Toxins (Basel) 2020;12:E794. [PMID: 33322178 DOI: 10.3390/toxins12120794] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
8 Olsson A, Gustavsen S, Nguyen TD, Nyman M, Langkilde AR, Hansen TH, Sellebjerg F, Oturai AB, Bach Søndergaard H. Serum Short-Chain Fatty Acids and Associations With Inflammation in Newly Diagnosed Patients With Multiple Sclerosis and Healthy Controls. Front Immunol 2021;12:661493. [PMID: 34025661 DOI: 10.3389/fimmu.2021.661493] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
9 Zhao T, Zhu Y, Yao L, Liu L, Li N. IGF-1 alleviates CCL4-induced hepatic cirrhosis and dysfunction of intestinal barrier through inhibition TLR4/NF-κB signaling mediated by down-regulation HMGB1. Ann Hepatol 2021;:100560. [PMID: 34653689 DOI: 10.1016/j.aohep.2021.100560] [Reference Citation Analysis]
10 Ahtesh FB, Stojanovska L, Apostolopoulos V. Anti-hypertensive peptides released from milk proteins by probiotics. Maturitas 2018;115:103-9. [PMID: 30049341 DOI: 10.1016/j.maturitas.2018.06.016] [Cited by in Crossref: 26] [Cited by in F6Publishing: 19] [Article Influence: 6.5] [Reference Citation Analysis]
11 Zheng D, Zhou H, Wang H, Zhu Y, Wu Y, Li Q, Li T, Liu L. Mesenchymal stem cell-derived microvesicles improve intestinal barrier function by restoring mitochondrial dynamic balance in sepsis rats. Stem Cell Res Ther 2021;12:299. [PMID: 34039427 DOI: 10.1186/s13287-021-02363-0] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
12 Li LZ, Tao SB, Ma L, Fu P. Roles of short-chain fatty acids in kidney diseases. Chin Med J (Engl) 2019;132:1228-32. [PMID: 30946066 DOI: 10.1097/CM9.0000000000000228] [Cited by in Crossref: 9] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
13 Camara-Lemarroy CR, Silva C, Greenfield J, Liu WQ, Metz LM, Yong VW. Biomarkers of intestinal barrier function in multiple sclerosis are associated with disease activity. Mult Scler 2020;26:1340-50. [PMID: 31317818 DOI: 10.1177/1352458519863133] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 4.0] [Reference Citation Analysis]
14 Zeng Q, Shen J, Chen K, Zhou J, Liao Q, Lu K, Yuan J, Bi F. The alteration of gut microbiome and metabolism in amyotrophic lateral sclerosis patients. Sci Rep 2020;10:12998. [PMID: 32747678 DOI: 10.1038/s41598-020-69845-8] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 6.0] [Reference Citation Analysis]
15 Ou Z, Zhu L, Huang C, Ma C, Kong L, Lin X, Gao X, Huang L, Wen L, Liang Z, Yuan Z, Wu J, Yi J. Betulinic acid attenuates cyclophosphamide-induced intestinal mucosa injury by inhibiting the NF-κB/MAPK signalling pathways and activating the Nrf2 signalling pathway. Ecotoxicol Environ Saf 2021;225:112746. [PMID: 34482064 DOI: 10.1016/j.ecoenv.2021.112746] [Reference Citation Analysis]
16 Meng X, Zhou HY, Shen HH, Lufumpa E, Li XM, Guo B, Li BZ. Microbe-metabolite-host axis, two-way action in the pathogenesis and treatment of human autoimmunity. Autoimmun Rev 2019;18:455-75. [PMID: 30844549 DOI: 10.1016/j.autrev.2019.03.006] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 6.7] [Reference Citation Analysis]
17 Chatzikonstantinou S, Poulidou V, Arnaoutoglou M, Kazis D, Heliopoulos I, Grigoriadis N, Boziki M. Signaling through the S1P-S1PR Axis in the Gut, the Immune and the Central Nervous System in Multiple Sclerosis: Implication for Pathogenesis and Treatment. Cells 2021;10:3217. [PMID: 34831439 DOI: 10.3390/cells10113217] [Reference Citation Analysis]
18 Olsson A, Gustavsen S, Langkilde AR, Hansen TH, Sellebjerg F, Bach Søndergaard H, Oturai AB. Circulating levels of tight junction proteins in multiple sclerosis: Association with inflammation and disease activity before and after disease modifying therapy. Mult Scler Relat Disord 2021;54:103136. [PMID: 34247104 DOI: 10.1016/j.msard.2021.103136] [Reference Citation Analysis]
19 D'Amato A, Di Cesare Mannelli L, Lucarini E, Man AL, Le Gall G, Branca JJV, Ghelardini C, Amedei A, Bertelli E, Regoli M, Pacini A, Luciani G, Gallina P, Altera A, Narbad A, Gulisano M, Hoyles L, Vauzour D, Nicoletti C. Faecal microbiota transplant from aged donor mice affects spatial learning and memory via modulating hippocampal synaptic plasticity- and neurotransmission-related proteins in young recipients. Microbiome 2020;8:140. [PMID: 33004079 DOI: 10.1186/s40168-020-00914-w] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 9.5] [Reference Citation Analysis]
20 Parodi B, Sanna A, Cedola A, Uccelli A, Kerlero de Rosbo N. Hydroxycarboxylic Acid Receptor 2, a Pleiotropically Linked Receptor for the Multiple Sclerosis Drug, Monomethyl Fumarate. Possible Implications for the Inflammatory Response. Front Immunol 2021;12:655212. [PMID: 34084164 DOI: 10.3389/fimmu.2021.655212] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
21 Haupeltshofer S, Leichsenring T, Berg S, Pedreiturria X, Joachim SC, Tischoff I, Otte JM, Bopp T, Fantini MC, Esser C, Willbold D, Gold R, Faissner S, Kleiter I. Smad7 in intestinal CD4+ T cells determines autoimmunity in a spontaneous model of multiple sclerosis. Proc Natl Acad Sci U S A 2019;116:25860-9. [PMID: 31796589 DOI: 10.1073/pnas.1905955116] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
22 Buscarinu MC, Gargano F, Lionetto L, Capi M, Morena E, Fornasiero A, Reniè R, Landi AC, Pellicciari G, Romano C, Mechelli R, Romano S, Borsellino G, Battistini L, Simmaco M, Fagnani C, Salvetti M, Ristori G. Intestinal Permeability and Circulating CD161+CCR6+CD8+T Cells in Patients With Relapsing-Remitting Multiple Sclerosis Treated With Dimethylfumarate. Front Neurol 2021;12:683398. [PMID: 34512507 DOI: 10.3389/fneur.2021.683398] [Reference Citation Analysis]
23 Qiu Y, Chen X, Yan X, Wang J, Yu G, Ma W, Xiao B, Quinones S, Tian X, Ren X. Gut microbiota perturbations and neurodevelopmental impacts in offspring rats concurrently exposure to inorganic arsenic and fluoride. Environment International 2020;140:105763. [DOI: 10.1016/j.envint.2020.105763] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
24 Walrath T, Dyamenahalli KU, Hulsebus HJ, McCullough RL, Idrovo JP, Boe DM, McMahan RH, Kovacs EJ. Age-related changes in intestinal immunity and the microbiome. J Leukoc Biol 2021;109:1045-61. [PMID: 33020981 DOI: 10.1002/JLB.3RI0620-405RR] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
25 Yeganeh Salehpour M, Mollica A, Momtaz S, Sanadgol N, Farzaei MH. Melatonin and Multiple Sclerosis: From Plausible Neuropharmacological Mechanisms of Action to Experimental and Clinical Evidence. Clin Drug Investig 2019;39:607-24. [PMID: 31054087 DOI: 10.1007/s40261-019-00793-6] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
26 Duncan ID, Watters JJ. Remyelination and the gut-brain axis. Proc Natl Acad Sci U S A 2019;116:24922-4. [PMID: 31767768 DOI: 10.1073/pnas.1918897116] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
27 Shi J, Zhao XH, Fu Y, Lametsch R. Transglutaminase-Mediated Caseinate Oligochitosan Glycation Enhances the Effect of Caseinate Hydrolysate to Ameliorate the LPS-Induced Damage on the Intestinal Barrier Function in IEC-6 Cells. J Agric Food Chem 2021;69:8787-96. [PMID: 34323484 DOI: 10.1021/acs.jafc.1c02858] [Reference Citation Analysis]
28 Lasconi C, Pahl MC, Cousminer DL, Doege CA, Chesi A, Hodge KM, Leonard ME, Lu S, Johnson ME, Su C, Hammond RK, Pippin JA, Terry NA, Ghanem LR, Leibel RL, Wells AD, Grant SFA. Variant-to-Gene-Mapping Analyses Reveal a Role for the Hypothalamus in Genetic Susceptibility to Inflammatory Bowel Disease. Cell Mol Gastroenterol Hepatol 2021;11:667-82. [PMID: 33069917 DOI: 10.1016/j.jcmgh.2020.10.004] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
29 [DOI: 10.1101/866459] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
30 El-Hakim Y, Mani KK, Eldouh A, Pandey S, Grimaldo MT, Dabney A, Pilla R, Sohrabji F. Sex differences in stroke outcome correspond to rapid and severe changes in gut permeability in adult Sprague-Dawley rats. Biol Sex Differ 2021;12:14. [PMID: 33451354 DOI: 10.1186/s13293-020-00352-1] [Reference Citation Analysis]
31 Khan H, Sureda A, Belwal T, Çetinkaya S, Süntar İ, Tejada S, Devkota HP, Ullah H, Aschner M. Polyphenols in the treatment of autoimmune diseases. Autoimmun Rev 2019;18:647-57. [PMID: 31059841 DOI: 10.1016/j.autrev.2019.05.001] [Cited by in Crossref: 62] [Cited by in F6Publishing: 48] [Article Influence: 20.7] [Reference Citation Analysis]
32 Blais LL, Montgomery TL, Amiel E, Deming PB, Krementsov DN. Probiotic and commensal gut microbial therapies in multiple sclerosis and its animal models: a comprehensive review. Gut Microbes 2021;13:1943289. [PMID: 34264791 DOI: 10.1080/19490976.2021.1943289] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
33 Wang M, Guo J, Zhao YQ, Wang JP. IL-21 mediates microRNA-423-5p /claudin-5 signal pathway and intestinal barrier function in inflammatory bowel disease. Aging (Albany NY) 2020;12:16099-110. [PMID: 32855360 DOI: 10.18632/aging.103566] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
34 Esmaeil Amini M, Shomali N, Bakhshi A, Rezaei S, Hemmatzadeh M, Hosseinzadeh R, Eslami S, Babaie F, Aslani S, Torkamandi S, Mohammadi H. Gut microbiome and multiple sclerosis: New insights and perspective. Int Immunopharmacol 2020;88:107024. [PMID: 33182024 DOI: 10.1016/j.intimp.2020.107024] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
35 Branca JJV, Gulisano M, Nicoletti C. Intestinal epithelial barrier functions in ageing. Ageing Res Rev 2019;54:100938. [PMID: 31369869 DOI: 10.1016/j.arr.2019.100938] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 6.3] [Reference Citation Analysis]
36 Wang S, Wang R, Li GQ, Cho JL, Deng Y, Li Y. Myosin light chain kinase mediates intestinal barrier dysfunction following simulated microgravity based on proteomic strategy. J Proteomics 2021;231:104001. [PMID: 33035716 DOI: 10.1016/j.jprot.2020.104001] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
37 Boziki MK, Kesidou E, Theotokis P, Mentis AA, Karafoulidou E, Melnikov M, Sviridova A, Rogovski V, Boyko A, Grigoriadis N. Microbiome in Multiple Sclerosis; Where Are We, What We Know and Do Not Know. Brain Sci 2020;10:E234. [PMID: 32295236 DOI: 10.3390/brainsci10040234] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 8.5] [Reference Citation Analysis]
38 Zheng J, Wang H, Deng Z, Shan Y, Lü X, Zhao X. Structure and biological activities of glycoproteins and their metabolites in maintaining intestinal health. Crit Rev Food Sci Nutr 2021;:1-16. [PMID: 34619993 DOI: 10.1080/10408398.2021.1987857] [Reference Citation Analysis]
39 Moisset X, Giraud P, Dallel R. Migraine in multiple sclerosis and other chronic inflammatory diseases. Rev Neurol (Paris) 2021:S0035-3787(21)00616-0. [PMID: 34325914 DOI: 10.1016/j.neurol.2021.07.005] [Reference Citation Analysis]
40 Fleiss B, Van Steenwinckel J, Bokobza C, K Shearer I, Ross-Munro E, Gressens P. Microglia-Mediated Neurodegeneration in Perinatal Brain Injuries. Biomolecules 2021;11:99. [PMID: 33451166 DOI: 10.3390/biom11010099] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 6.0] [Reference Citation Analysis]
41 Helmink BA, Khan MAW, Hermann A, Gopalakrishnan V, Wargo JA. The microbiome, cancer, and cancer therapy. Nat Med 2019;25:377-88. [DOI: 10.1038/s41591-019-0377-7] [Cited by in Crossref: 250] [Cited by in F6Publishing: 218] [Article Influence: 83.3] [Reference Citation Analysis]
42 Antonini M, Lo Conte M, Sorini C, Falcone M. How the Interplay Between the Commensal Microbiota, Gut Barrier Integrity, and Mucosal Immunity Regulates Brain Autoimmunity. Front Immunol 2019;10:1937. [PMID: 31475000 DOI: 10.3389/fimmu.2019.01937] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 4.3] [Reference Citation Analysis]
43 Camara-Lemarroy CR, Metz LM, Yong VW. Focus on the gut-brain axis: Multiple sclerosis, the intestinal barrier and the microbiome. World J Gastroenterol 2018; 24(37): 4217-4223 [PMID: 30310254 DOI: 10.3748/wjg.v24.i37.4217] [Cited by in CrossRef: 25] [Cited by in F6Publishing: 23] [Article Influence: 6.3] [Reference Citation Analysis]
44 Herath M, Hosie S, Bornstein JC, Franks AE, Hill-Yardin EL. The Role of the Gastrointestinal Mucus System in Intestinal Homeostasis: Implications for Neurological Disorders. Front Cell Infect Microbiol 2020;10:248. [PMID: 32547962 DOI: 10.3389/fcimb.2020.00248] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 5.0] [Reference Citation Analysis]
45 Chen Z, Lin S, Jiang Y, Liu L, Jiang J, Chen S, Tong Y, Wang P. Effects of Bread Yeast Cell Wall Beta-Glucans on Mice with Loperamide-Induced Constipation. Journal of Medicinal Food 2019;22:1009-21. [DOI: 10.1089/jmf.2019.4407] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 2.7] [Reference Citation Analysis]
46 Sjöström B, Bredberg A, Mandl T, Alonso-Magdalena L, Ohlsson B, Lavasani S, Nouri M, Henriksson G. Increased intestinal permeability in primary Sjögren's syndrome and multiple sclerosis. J Transl Autoimmun 2021;4:100082. [PMID: 33506194 DOI: 10.1016/j.jtauto.2021.100082] [Reference Citation Analysis]
47 Kozieł MJ, Ziaja M, Piastowska-Ciesielska AW. Intestinal Barrier, Claudins and Mycotoxins. Toxins (Basel) 2021;13:758. [PMID: 34822542 DOI: 10.3390/toxins13110758] [Reference Citation Analysis]
48 Sharma L, Riva A. Intestinal Barrier Function in Health and Disease-Any role of SARS-CoV-2? Microorganisms 2020;8:E1744. [PMID: 33172188 DOI: 10.3390/microorganisms8111744] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
49 Guo Y, Zhu X, Zeng M, Qi L, Tang X, Wang D, Zhang M, Xie Y, Li H, Yang X, Chen D. A diet high in sugar and fat influences neurotransmitter metabolism and then affects brain function by altering the gut microbiota. Transl Psychiatry 2021;11:328. [PMID: 34045460 DOI: 10.1038/s41398-021-01443-2] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
50 Zhang H, Liu M, Liu X, Zhong W, Li Y, Ran Y, Guo L, Chen X, Zhao J, Wang B, Zhou L. Bifidobacterium animalis ssp. Lactis 420 Mitigates Autoimmune Hepatitis Through Regulating Intestinal Barrier and Liver Immune Cells. Front Immunol. 2020;11:569104. [PMID: 33123141 DOI: 10.3389/fimmu.2020.569104] [Cited by in Crossref: 4] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
51 Duan H, Yu L, Tian F, Zhai Q, Fan L, Chen W. Antibiotic-induced gut dysbiosis and barrier disruption and the potential protective strategies. Crit Rev Food Sci Nutr 2020;:1-26. [PMID: 33198506 DOI: 10.1080/10408398.2020.1843396] [Cited by in Crossref: 3] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]